FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100991860> ?p ?o ?g. }

• W2100991860 endingPage "300" @default.
• W2100991860 startingPage "293" @default.
• W2100991860 abstract "Benzoyl peroxide (BPO) was introduced in the treatment of acne in 1934. Despite the fact that only few randomized trials have been published, BPO is considered the standard in topical acne treatment. Anaerobic bacteria are reduced by oxidative mechanisms and the induction of resistant strains is reduced. Topical formulations are available at concentrations of 2.5, 5, 10 and 20 %. The effect is dose-dependent, but the irritation increases with higher concentrations. Usually 5 % BPO is sufficient to control acne grade I-II. Due to its strong oxidative potential, patients should be advised that BPO may bleach colored and dark clothing, bedding and even hair. BPO is safe for use in pregnant and lactating females because it is degraded to benzoic acid. It is a cost-effective treatment for acne grade I-II. Patients with papulopustular acne grade I-II, particularly with marked inflammation, show satisfactory improvement with topical antibiotic treatment. The following compounds are available and effective: erythromycin, clindamycin and tetracycline (the latter being less frequently used). A review in 1990 suggested that topical tetracycline was ineffective in the treatment of acne. Along with eliminating Propionibacterium acnes, the main mechanism of topical antibiotics is their antiinflammatory effect. All three penetrate the epidermal barrier well and are similarly efficacious. Randomized trials have shown that in concentrations of 2-4 %, their effects are comparable to oral tetracycline and minocycline. Combination therapy with retinoids or benzoyl peroxide (BPO) increases efficacy. Retinoids increase penetration and reduce comedones, while topical antibiotics primarily address inflammation. One side effect of topical antibacterial treatment is an increase in drug-resistant resident skin flora with gram-negative microorganisms prevailing, which can lead to gram-negative folliculitis. All three antibiotics fluoresce under black light which may produce interesting effects in a discotheque. There are two reports of topical clindamycin causing pseudomembranous colitis after long-term and widespread usage. Azelaic acid has a predominant antibacterial action, although it is not considered as an antibiotic in the classical sense. Furthermore, it possesses a modest comedolytic effect. Burning upon application is common. Since azelaic acid is naturally present, systemic side effects are not likely to occur, making it safe for acne treatment during pregnancy and lactation." @default.
• W2100991860 created "2016-06-24" @default.
• W2100991860 creator A5029200478 @default.
• W2100991860 creator A5041682292 @default.
• W2100991860 date "2006-04-01" @default.
• W2100991860 modified "2023-10-18" @default.
• W2100991860 title "Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid" @default.
• W2100991860 cites W1934260536 @default.
• W2100991860 cites W1964675629 @default.
• W2100991860 cites W1969502034 @default.
• W2100991860 cites W1974688173 @default.
• W2100991860 cites W1976227153 @default.
• W2100991860 cites W1991426697 @default.
• W2100991860 cites W2003277258 @default.
• W2100991860 cites W2014792685 @default.
• W2100991860 cites W2022880272 @default.
• W2100991860 cites W2025802417 @default.
• W2100991860 cites W2026528135 @default.
• W2100991860 cites W2027229923 @default.
• W2100991860 cites W2039090017 @default.
• W2100991860 cites W2041029086 @default.
• W2100991860 cites W206234231 @default.
• W2100991860 cites W2071691443 @default.
• W2100991860 cites W2072161824 @default.
• W2100991860 cites W2076753611 @default.
• W2100991860 cites W2080028135 @default.
• W2100991860 cites W2080352519 @default.
• W2100991860 cites W2086865183 @default.
• W2100991860 cites W2089405377 @default.
• W2100991860 cites W2105448177 @default.
• W2100991860 cites W2110120472 @default.
• W2100991860 cites W2112036613 @default.
• W2100991860 cites W2168993994 @default.
• W2100991860 cites W2171863770 @default.
• W2100991860 cites W2409791029 @default.
• W2100991860 cites W4238286136 @default.
• W2100991860 cites W4241417144 @default.
• W2100991860 cites W4247880821 @default.
• W2100991860 cites W4248983139 @default.
• W2100991860 cites W4249257224 @default.
• W2100991860 cites W4253349821 @default.
• W2100991860 doi "https://doi.org/10.1111/j.1610-0387.2006.05931.x" @default.
• W2100991860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16638058" @default.
• W2100991860 hasPublicationYear "2006" @default.
• W2100991860 type Work @default.
• W2100991860 sameAs 2100991860 @default.
• W2100991860 citedByCount "62" @default.
• W2100991860 countsByYear W21009918602012 @default.
• W2100991860 countsByYear W21009918602013 @default.
• W2100991860 countsByYear W21009918602014 @default.
• W2100991860 countsByYear W21009918602015 @default.
• W2100991860 countsByYear W21009918602016 @default.
• W2100991860 countsByYear W21009918602017 @default.
• W2100991860 countsByYear W21009918602018 @default.
• W2100991860 countsByYear W21009918602019 @default.
• W2100991860 countsByYear W21009918602020 @default.
• W2100991860 countsByYear W21009918602021 @default.
• W2100991860 countsByYear W21009918602022 @default.
• W2100991860 countsByYear W21009918602023 @default.
• W2100991860 crossrefType "journal-article" @default.
• W2100991860 hasAuthorship W2100991860A5029200478 @default.
• W2100991860 hasAuthorship W2100991860A5041682292 @default.
• W2100991860 hasConcept C16005928 @default.
• W2100991860 hasConcept C178790620 @default.
• W2100991860 hasConcept C185592680 @default.
• W2100991860 hasConcept C203014093 @default.
• W2100991860 hasConcept C2777063393 @default.
• W2100991860 hasConcept C2777458120 @default.
• W2100991860 hasConcept C2777673923 @default.
• W2100991860 hasConcept C2778275353 @default.
• W2100991860 hasConcept C2778885487 @default.
• W2100991860 hasConcept C2779900937 @default.
• W2100991860 hasConcept C2780285341 @default.
• W2100991860 hasConcept C2780923616 @default.
• W2100991860 hasConcept C44228677 @default.
• W2100991860 hasConcept C501593827 @default.
• W2100991860 hasConcept C521977710 @default.
• W2100991860 hasConcept C55493867 @default.
• W2100991860 hasConcept C71924100 @default.
• W2100991860 hasConcept C98274493 @default.
• W2100991860 hasConceptScore W2100991860C16005928 @default.
• W2100991860 hasConceptScore W2100991860C178790620 @default.
• W2100991860 hasConceptScore W2100991860C185592680 @default.
• W2100991860 hasConceptScore W2100991860C203014093 @default.
• W2100991860 hasConceptScore W2100991860C2777063393 @default.
• W2100991860 hasConceptScore W2100991860C2777458120 @default.
• W2100991860 hasConceptScore W2100991860C2777673923 @default.
• W2100991860 hasConceptScore W2100991860C2778275353 @default.
• W2100991860 hasConceptScore W2100991860C2778885487 @default.
• W2100991860 hasConceptScore W2100991860C2779900937 @default.
• W2100991860 hasConceptScore W2100991860C2780285341 @default.
• W2100991860 hasConceptScore W2100991860C2780923616 @default.
• W2100991860 hasConceptScore W2100991860C44228677 @default.
• W2100991860 hasConceptScore W2100991860C501593827 @default.
• W2100991860 hasConceptScore W2100991860C521977710 @default.
• W2100991860 hasConceptScore W2100991860C55493867 @default.
• W2100991860 hasConceptScore W2100991860C71924100 @default.
• W2100991860 hasConceptScore W2100991860C98274493 @default.

• next